PARIS | The American group Pfizer, associated with the German laboratory BioNTech, announced on Saturday a “plan” which should make it possible to limit the delivery delays of the vaccine against COVID-19 to one week, while Europe feared that the deliveries of doses for “three to four weeks”.
• Read also: 100,000 fewer doses than expected in Quebec within a month
• Read also: Other countries resign themselves to Pfizer’s production cut
“Pfizer and BioNTech have developed a plan that will increase manufacturing capacity in Europe and deliver significantly more doses in the second quarter,” the two companies said in a joint statement.
“We will return to the original schedule of deliveries to the European Union from the week of January 25, with an increase in deliveries starting the week of February 15,” added the two groups.
“To do this, certain modifications to the production processes are now necessary,” said the two partners.
The American group Pfizer, associated with the German laboratory BioNTech, had unexpectedly warned on Friday that it was not going to be able, until early February, to provide EU countries with the weekly quantities to which it had obtained. engaged.
Berlin had mentioned a drop in pace “for three to four weeks”.
In their latest press release, Pfizer and BioNTech indicate that their Puurs plant “will experience a temporary reduction in the number of doses delivered in the coming week”.